April 26th 2023
The bill, H.R. 2474, would tie the Medicare physician fee schedule to the Medicare Economic Index (MEI), something the AACU and the AMA have long supported
Medicare fraud/abuse charges: 4 ways to protect your practice
May 1st 2015What can urologists do to protect themselves from being accused of and charged with health care fraud and abuse? Urologist Jeffrey Kaufman, MD, and attorneys J.D. Thomas, Esq and Laura F. Laemmle-Weidenfeld, Esq provide these four suggestions.
Urology groups reiterate support for USPSTF bill
April 1st 2015The major organizations representing urologists are continuing their push for congressional approval of legislation designed to reform the operations of the U.S. Preventive Services Task Force, which in May 2012 recommended against PSA-based screening for prostate cancer.
Narrow networks expand, raising concern
March 1st 2015Narrow provider networks are gaining ground among insurers and could impact patient access to urologists. While insurers tout the approach to care as a way to control costs and preserve quality, urologists and others question whether the payment model is all about cost.
Congress cuts coverage for erection devices
January 12th 2015Just over a year ago, the Office of Inspector General of the Department of Health and Human Services issued a report declaring that Medicare payments for vacuum erection systems were “grossly excessive” and recommended steps to remedy the situation.
Congress guts the IPAB, then takes on its role
December 31st 2014The 2015 omnibus spending bill canceled a $10 million appropriation for the Independent Payment Advisory Board (IPAB). Congress also approved a bill that cuts Medicare funding for vacuum erection systems. Rationing care, whether undertaken by the IPAB or Congress, must be opposed when it arbitrarily selects services based on public perception and not medical necessity, writes Ross E. Weber of the AACU.
Fight or flight: Why voicing your concerns is not enough
December 1st 2014In Urology Times’ ninth annual State of the Specialty survey, an astounding 87% of respondents perceived “increasing government regulations” with trepidation. Unfortunately, while nearly nine in ten urologists identify the problem, far fewer take steps to address it.
Pressure to expand Medicaid mounts, employer plans decline
November 3rd 2014When provisions of the Affordable Care Act (ACA) related to the expansion of Medicaid to low-income childless adults took effect in January 2014, 25 states and the District of Columbia had approved laws to broaden their programs' eligibility requirements. Since then, under pressure from various interests groups, including state hospital associations, lawmakers in at least three more states-Iowa, Michigan, and Pennsylvania-expanded their health care safety net programs and thereby gained access to federal dollars that would have otherwise been left on the table.
Prostate cancer council bill earns AUA support
October 10th 2014The effort to draw attention to the importance of prostate cancer detection was given a big boost in September when conservative Sen. Jeff Sessions (R-AR) and liberal Sen. Barbara Boxer (D-CA) joined together to sponsor legislation to create the National Prostate Cancer Council.
State Society conference: Vigilance in the political process essential
October 6th 2014Leaders of state, national, and subspecialty urologic societies from around the country converged in Rosemont, IL in September for a weekend of health policy discussions and advocacy tips with public officials, policy experts, and fellow urologists. One of the themes reinforced at the 7th Annual State Society Network Advocacy Conference, hosted by the AACU, was the importance and impact of physician engagement in the political process.
‘Open Payments’ moves forward despite snags
September 5th 2014Physicians, including urologists, now have another headache to deal with-making certain information about them published on the Internet by as part of the National Physician Payment Transparency Program (Open Payments) is accurate and not misleading to patients who want to know about the financial benefits their doctors receive from manufacturers of drugs, devices, and biologic and medical supplies.